Nowadays, one of the major global health concerns is coronavirus disease 2019 (COVID-
19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

At the end of 2019, a life threatening viral infection (COVID-19) caused by a novel
coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was …

The novel coronavirus disease 2019 (COVID-19) produced by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is sweeping the world in a very short time. Although …

A small but significant proportion of COVID‐19 patients develop life‐threatening cytokine
storm. We have developed a new anti‐inflammatory drug, EXO‐CD24, a combination of an …

The coronavirus disease 2019 (COVID-19) became a worldwide concern at the beginning of
2020 and has affected millions. Several previous studies revealed the impact of the …

Worldwide the pandemic of COVID-19 spreads rapidly and has had an enormous public
health impact with substantial morbidity and mortality especially in high-risk groups, such as …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has emerged to be the greatest threat to humanity in the …

Abstract Coronavirus disease 2019 (COVID-19) is a rapidly evolving infectious/inflammatory
disorder which has turned into a global pandemic. With severe acute respiratory syndrome …

Some studies reported that genomic RNA of SARS-CoV-2 can absorb a few host miRNAs
that regulate immune-related genes and then deprive their function. In this perspective, we …

Background The absence of specific antivirals to treat COVID-19 leads to the repositioning
of candidates' drugs. Nitazoxanide (NTZ) has a broad antiviral effect. Methods This was a …